APRECIA PHARMACEUTICALS LLC
23Patents
23Active
23Granted
52Portfolio score
Filing activity: May 18, 2007 → Nov 17, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8888480B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 101 | Active |
| US9517591B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 38 | Active |
| US9517592B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 38 | Active |
| US9908293B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 24 | Active |
| US9339489B2 | Rapid disperse dosage form containing levetiracetam | Human Necessities | 18 | Active |
| US9314429B2 | Rapidly dispersible dosage form of oxcarbazepine | Performing Operations; Transporting | 16 | Active |
| US8828411B2 | Dosage forms and methods of use thereof | Performing Operations; Transporting | 14 | Active |
| US9610735B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 12 | Active |
| US9492380B2 | Rapidly dispersible dosage form of topiramate | Human Necessities | 7 | Active |
| US9669009B2 | Rapid disperse dosage form containing levetiracetam | Human Necessities | 5 | Active |
| US9616018B2 | Rapidly dispersible dosage form of oxcarbazepine | Performing Operations; Transporting | 5 | Active |
| US10449712B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 3 | Active |
| US10118335B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 2 | Active |
| US10420785B2 | Rapidly dispersible dosage form of topiramate | Human Necessities | 2 | Active |
| US10028909B2 | Rapidly dispersible dosage form of oxcarbazepine | Performing Operations; Transporting | 1 | Active |
| US11383440B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 1 | Active |
| US11278501B2 | Method and system for forming a dosage form within a packaging | Performing Operations; Transporting | 0 | Active |
| US12202196B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 0 | Active |
| US11160786B2 | Rapid disperse dosage form | Human Necessities | 0 | Active |
| US12396979B2 | Rapid disperse dosage form | Human Necessities | 0 | Active |
| US11597150B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 0 | Active |
| US11097483B2 | Three-dimensional printing system and equipment assembly | Emerging Cross-Sectional Technologies | 0 | Active |
| US11433022B2 | Rapidly-orodispersible tablets having an in interior cavity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.